AAAAAA

   
Results: 1-21 |
Results: 21
PHASE-II TRIAL OF FLUDARABINE MONOPHOSPHATE IN PATIENTS WITH MANTLE-CELL LYMPHOMAS
Authors: DECAUDIN D BOSQ J TERTIAN G NEDELLEC G BENNACEUR A VENUAT AM BAYLE C CARDE P BENDAHMANE B HAYAT M MUNCK JN
Citation: D. Decaudin et al., PHASE-II TRIAL OF FLUDARABINE MONOPHOSPHATE IN PATIENTS WITH MANTLE-CELL LYMPHOMAS, Journal of clinical oncology, 16(2), 1998, pp. 579-583
SUCCESSFUL ALLOGENIC PERIPHERAL STEM-CELL TRANSPLANTATION (PSCT) FOR IGM GAMMOPATHY WITH SEVERE DEMYELINISATING POLYNEUROPATHY ASSOCIATED WITH SECONDARY MYELODYSPLASIA
Authors: DEREVEL T FELTEN D SOULEAU B DELAUNAY J VOLKMAN P BECQUET D NEDELLEC G
Citation: T. Derevel et al., SUCCESSFUL ALLOGENIC PERIPHERAL STEM-CELL TRANSPLANTATION (PSCT) FOR IGM GAMMOPATHY WITH SEVERE DEMYELINISATING POLYNEUROPATHY ASSOCIATED WITH SECONDARY MYELODYSPLASIA, Bone marrow transplantation, 21, 1998, pp. 130-130
G-CSF MOBILIZED PERIPHERAL STEM-CELLS AS DONOR CELL THERAPY FOR AN ACUTE MYELOID-LEUKEMIA RELAPSING POST BMT
Authors: DEREVEL T SOULEAU B DESANGLES F BOURIN P JOUSSEMET M NEDELLEC G
Citation: T. Derevel et al., G-CSF MOBILIZED PERIPHERAL STEM-CELLS AS DONOR CELL THERAPY FOR AN ACUTE MYELOID-LEUKEMIA RELAPSING POST BMT, Bone marrow transplantation, 21, 1998, pp. 232-232
PROGNOSTIC FACTORS FOR SURVIVAL AND RESPONSE AFTER HIGH-DOSE THERAPY (HDT) AND AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) FOR SYSTEMIC AMYLOIDOSIS (AL) - A REPORT ON 22 CASES
Authors: MOREAU P LEBLOND V BOURQUELOT P FACON T ATTAL M CAILLOT D AUDHUY B NEDELLEC G HUYNH A FERRANT A BATAILLE R HAROUSSEAU JL
Citation: P. Moreau et al., PROGNOSTIC FACTORS FOR SURVIVAL AND RESPONSE AFTER HIGH-DOSE THERAPY (HDT) AND AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) FOR SYSTEMIC AMYLOIDOSIS (AL) - A REPORT ON 22 CASES, Bone marrow transplantation, 21, 1998, pp. 713-713
PROGNOSTIC FACTORS FOR SURVIVAL AND RESPONSE AFTER HIGH-DOSE THERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION IN SYSTEMIC AL AMYLOIDOSIS - A REPORT ON 21 PATIENTS
Authors: MOREAU P LEBLOND V BOURQUELOT P FACON T HUYNH A CAILLOT D HERMINE O ATTAL M HAMIDOU M NEDELLEC G FERRANT A AUDHUY B BATAILLE R MILPIED N HAROUSSEAU JL
Citation: P. Moreau et al., PROGNOSTIC FACTORS FOR SURVIVAL AND RESPONSE AFTER HIGH-DOSE THERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION IN SYSTEMIC AL AMYLOIDOSIS - A REPORT ON 21 PATIENTS, British Journal of Haematology, 101(4), 1998, pp. 766-769
TREATMENT-RELATED DEATHS AND 2ND CANCER RISK AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR HODGKINS-DISEASE
Authors: ANDRE M HENRYAMAR M BLAISE D COLOMBAT P FLEURY J MILPIED N CAHN JY PICO JL BASTION Y KUENTZ M NEDELLEC G ATTAL M FERME C GISSELBRECHT C
Citation: M. Andre et al., TREATMENT-RELATED DEATHS AND 2ND CANCER RISK AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR HODGKINS-DISEASE, Blood, 92(6), 1998, pp. 1933-1940
THE USE OF A SEQUENTIAL HIGH-DOSE RECOMBINANT INTERLEUKIN-2 REGIMEN AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION DOES NOT IMPROVE THE DISEASE-FREE SURVIVAL OF PATIENTS WITH ACUTE-LEUKEMIA TRANSPLANTED IN FIRSTCOMPLETE REMISSION
Authors: BLAISE D ATTAL M PICO JL REIFFERS J STOPPA AM BELLANGER C MOLINA L NEDELLEC G VERNANT JP LEGROS M GABUS R HUGUET F BRANDELY M HERCEND T OLIVE D MARANINCHI D
Citation: D. Blaise et al., THE USE OF A SEQUENTIAL HIGH-DOSE RECOMBINANT INTERLEUKIN-2 REGIMEN AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION DOES NOT IMPROVE THE DISEASE-FREE SURVIVAL OF PATIENTS WITH ACUTE-LEUKEMIA TRANSPLANTED IN FIRSTCOMPLETE REMISSION, Leukemia & lymphoma, 25(5-6), 1997, pp. 469-478
INTENSIVE CHEMOTHERAPY WITH IDARUBICIN, CYTOSINE-ARABINOSIDE, AND GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) IN PATIENTS WITH SECONDARY AND THERAPY-RELATED ACUTE MYELOGENOUS LEUKEMIA
Authors: GARDIN C CHAIBI P DEREVEL T ROUSSELOT P TURLURE P MICLEA JM NEDELLEC G DOMBRET H
Citation: C. Gardin et al., INTENSIVE CHEMOTHERAPY WITH IDARUBICIN, CYTOSINE-ARABINOSIDE, AND GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) IN PATIENTS WITH SECONDARY AND THERAPY-RELATED ACUTE MYELOGENOUS LEUKEMIA, Leukemia, 11(1), 1997, pp. 16-21
HIGH-DOSE THERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) FORSYSTEMIC AL AMYLOIDOSIS (AL) - A REPORT ON 16 CASES
Authors: MOREAU P FACON T LEBLOND V ATTAL M CAILLOT D NEDELLEC G HUYNH A BATAILLE R HAROUSSEAU JL
Citation: P. Moreau et al., HIGH-DOSE THERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) FORSYSTEMIC AL AMYLOIDOSIS (AL) - A REPORT ON 16 CASES, Experimental hematology, 25(8), 1997, pp. 205-205
PROGNOSTIC FACTORS FOR SURVIVAL AND RESPONSE AFTER HIGH-DOSE THERAPY (HDT) AND AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) FOR SYSTEMIC AMYLOIDOSIS (AL) - A REPORT ON 22 CASES
Authors: MOREAU P LEBLOND V BOURQUELOT P FACON T ATTAL M CAILLOT D AUDHUY B NEDELLEC G HUYNH A FERRANT A BATAILLE R HAROUSSEAU JL
Citation: P. Moreau et al., PROGNOSTIC FACTORS FOR SURVIVAL AND RESPONSE AFTER HIGH-DOSE THERAPY (HDT) AND AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) FOR SYSTEMIC AMYLOIDOSIS (AL) - A REPORT ON 22 CASES, Blood, 90(10), 1997, pp. 490-490
ANALYSIS OF PROGNOSTIC FACTORS AFTER THE FIRST RELAPSE OF HODGKINS-DISEASE IN 187 PATIENTS
Authors: BRICE P BASTION Y DIVINE M NEDELLEC G FERRANT A GABARRE J REMAN O LEPAGE E FERME C
Citation: P. Brice et al., ANALYSIS OF PROGNOSTIC FACTORS AFTER THE FIRST RELAPSE OF HODGKINS-DISEASE IN 187 PATIENTS, Cancer, 78(6), 1996, pp. 1293-1299
AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) IMPROVES SURVIVAL OF REFRACTORY HODGKINS-DISEASE (HD) PATIENTS - A RETROSPECTIVE MATCH-CONTROLLED STUDY
Authors: ANDRE M HENRYAMAR M PICO JL BASTION Y BLAISE D KUENTZ M COLOMBAT P CAHN JY ATTAL M FLEURY J MILPIED N BIRON P NEDELLEC G JOUET JP TILLY R FERME C GISSELBRECHT C
Citation: M. Andre et al., AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) IMPROVES SURVIVAL OF REFRACTORY HODGKINS-DISEASE (HD) PATIENTS - A RETROSPECTIVE MATCH-CONTROLLED STUDY, Blood, 88(10), 1996, pp. 479-479
IS FLUDARABINE EFFICIENT IN MANTLE CELL LYMPHOMAS
Authors: DECAUDIN D MUNCK JN NEDELLEC G TERTIAN G BENDAHMANE B BENNACEUR AL BOSQ J ULUSAKARYA A CASTAGNA L BOURHIS JH PICO JL HAYAT M
Citation: D. Decaudin et al., IS FLUDARABINE EFFICIENT IN MANTLE CELL LYMPHOMAS, Blood, 88(10), 1996, pp. 2262-2262
THE MINE REGIMEN AS INTENSIVE SALVAGE CHEMOTHERAPY FOR RELAPSED AND REFRACTORY HODGKINS-DISEASE
Authors: FERME C BASTION Y LEPAGE E BERGER F BRICE P MOREL P GABARRE J NEDELLEC G REMAN O CHERON N OBERLIN O COIFFIER B
Citation: C. Ferme et al., THE MINE REGIMEN AS INTENSIVE SALVAGE CHEMOTHERAPY FOR RELAPSED AND REFRACTORY HODGKINS-DISEASE, Annals of oncology, 6(6), 1995, pp. 543-549
HEMATOPOIETIC GROWTH-FACTORS IN DRUG-INDUCED AGRANULOCYTOSIS
Authors: HUNAULT M DOMBRET H GARDIN C RIO B HERMINE O BRICE P DEVIDAS A TURLURE P ZINI JM NEDELLEC G SUTTON L MICLEA JM DEREVEL T DUPUY E PAUTIER P MAROLLEAU JP DELMER A
Citation: M. Hunault et al., HEMATOPOIETIC GROWTH-FACTORS IN DRUG-INDUCED AGRANULOCYTOSIS, Leukemia, 9(7), 1995, pp. 1286-1287
ADULT PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA (PH-MARROW TRANSPLANTATION (BMT) - SUCCESSFUL TREATMENT WITH DONOR LEUKOCYTE INFUSIONS( ALL) IN RELAPSE AFTER ALLOGENIC BONE)
Authors: RAFFOUX E DEREVEL T PIGNON JM NEDELLEC G MORSCHHAUSER F TOURNILHAC O BOURIN P JOUSSEMET M AUZANNEAU G
Citation: E. Raffoux et al., ADULT PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA (PH-MARROW TRANSPLANTATION (BMT) - SUCCESSFUL TREATMENT WITH DONOR LEUKOCYTE INFUSIONS( ALL) IN RELAPSE AFTER ALLOGENIC BONE), Experimental hematology, 23(8), 1995, pp. 858-858
ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR POSTPOLYCYTHEMIC MYELOID METAPLASIA WITH MYELOFIBROSIS - A CASE-REPORT
Authors: DEREVEL T GIRAUDIER S NEDELLEC G JOUSSEMET M BOURIN P SCHILL H GAILLARD JF AUZANNEAU G
Citation: T. Derevel et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR POSTPOLYCYTHEMIC MYELOID METAPLASIA WITH MYELOFIBROSIS - A CASE-REPORT, Bone marrow transplantation, 16(1), 1995, pp. 187-189
CONSOLIDATION TREATMENT OF ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - A PROSPECTIVE, RANDOMIZED TRIAL COMPARING ALLOGENEIC VERSUS AUTOLOGOUS BONE-MARROW TRANSPLANTATION AND TESTING THE IMPACT OF RECOMBINANT INTERLEUKIN-2 AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION
Authors: ATTAL M BLAISE D MARIT G PAYEN C MICHALLET M VERNANT JP SAUVAGE C TROUSSARD X NEDELLEC G PICO J HUGUET F STOPPA AM BROUSTET A SOTTO JJ PRIS J MARANINCHI D REIFFERS J
Citation: M. Attal et al., CONSOLIDATION TREATMENT OF ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - A PROSPECTIVE, RANDOMIZED TRIAL COMPARING ALLOGENEIC VERSUS AUTOLOGOUS BONE-MARROW TRANSPLANTATION AND TESTING THE IMPACT OF RECOMBINANT INTERLEUKIN-2 AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION, Blood, 86(4), 1995, pp. 1619-1628
INTENSIVE CHEMOTHERAPY WITH IDARUBICIN, CYTOSINE-ARABINOSIDE, AND G-CSF IN PATIENTS WITH SECONDARY AND THERAPY-RELATED ACUTE MYELOGENOUS LEUKEMIA
Authors: CHAIBI P GARDIN C DEREVEL T ROUSSELOT P TURLURE P KULEKCISAUVAGE C VEIL A SUTTON L MICLEA JM NEDELLEC G DOMBRET H
Citation: P. Chaibi et al., INTENSIVE CHEMOTHERAPY WITH IDARUBICIN, CYTOSINE-ARABINOSIDE, AND G-CSF IN PATIENTS WITH SECONDARY AND THERAPY-RELATED ACUTE MYELOGENOUS LEUKEMIA, Blood, 86(10), 1995, pp. 2061-2061
MINE CHEMOTHERAPY PLUS RHGM-CSF AS SALVAGE AND PERIPHERAL-BLOOD PROGENITOR CELLS MOBILIZING REGIMEN FOR RELAPSED OR REFRACTORY HODGKINS-DISEASE (HD)
Authors: FERME C BRICE P GABARRE J DIVINE M DETOURMIGNIES L JAUBERT J CAILLOT D BASTION Y ASSOULINE D NEDELLEC G ISNARD F TABAH I
Citation: C. Ferme et al., MINE CHEMOTHERAPY PLUS RHGM-CSF AS SALVAGE AND PERIPHERAL-BLOOD PROGENITOR CELLS MOBILIZING REGIMEN FOR RELAPSED OR REFRACTORY HODGKINS-DISEASE (HD), Blood, 84(10), 1994, pp. 10000162-10000162
CONSOLIDATION TREATMENT OF ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) -A PROSPECTIVE-STUDY COMPARING ALLO-BMT VERSUS AUTO-BMT, AND TESTING THE IMPACT OF IL2 AFTER AUTO-BMT
Authors: ATTAL M BLAISE D MARRIT G MICHALET M VERNANT JP SAUVAGE C TROUSSARD X NEDELLEC G PICO J HUGUET F STOPPA AM SOTTO JJ REIFFERS J MARANINCHI D PAVEN C PRIS J
Citation: M. Attal et al., CONSOLIDATION TREATMENT OF ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) -A PROSPECTIVE-STUDY COMPARING ALLO-BMT VERSUS AUTO-BMT, AND TESTING THE IMPACT OF IL2 AFTER AUTO-BMT, Blood, 84(10), 1994, pp. 10000251-10000251
Risultati: 1-21 |